Fellowships-Non Federal
Search Funding
Funding Resources
Funding Newsletter Archive
|
|
|
Greetings!
We hope that you find this publication helpful in your funding search. We also encourage you to visit our intranet funding page, which offers more information on funding resources available to faculty and fellows.
|
DFCI Limited Applications
| Please follow the link below to see announcements of current internal deadlines, how the process works, and contact information.
DFCI Limited Applications
|
|
|
|
|
Internal Funding
| No opportunities are available at this time.
|
Federal Funding
| |
Non-Federal Funding-Grants
A-T Children's Project
Grant Proposal
A-T Children's Project strives to assist respected scientists around the world in developing a clearer understanding of ataxia-telangiectasia. A-T Children's Project is determined to find a timely cure, or life-improving treatments, for this serious disease. A-T Children's Project is currently focusing its funding efforts on proposals that apply innovative and novel strategies for suggesting, developing and evaluating specific disease-modifying and symptomatic interventions. Proposals from junior investigators, from scientists in related disciplines, and from individuals with innovative new ideas for A-T research are particularly encouraged, as are laboratories and teams working together from industry, as well as teaching universities. National as well as international scientists are welcome to apply for funding.
Amount: $75,000/ year for 2 years
Deadline: LOI; September 1, 2015
Leukemia and Lymphoma Society (LLS)
Scholar Award
LLS is a national voluntary health agency dedicated to the conquest of hematologic malignancies and relevant premalignant conditions. Applicants should have held a faculty-level, tenure-track position for less than or equal to 8 years at the time of review (January 1, 2016). Applicants may submit only 1 application. There is a limit of 1 Fellow application per application cycle for each Sponsor, as well as one Special Fellow application per application cycle for each Sponsor. There is no limit to the number of applications submitted from a specific institution, nor is there a limit to the number of Scholar applications from any Sponsor. It is also acceptable for a Sponsor who currently has an active Fellow and/or Special Fellow Awardee in his/her lab to sponsor a Fellow and/or Special Fellow applicant during another award cycle. No other comparable (or better) career development award may be held prior to, or at the time of the grant start date (July 1, 2016). If a comparable (or better) career development award is obtained after receiving a Scholar Award, the LLS Award must be relinquished. Applicants must be the PI on a peer-reviewed research grant from a national agency (e.g., NIH, NSF, ACS) or other independent source that supports the research costs of proposed work. The Scholar Award is intended to further develop the independent research careers of highly qualified investigators not to support well-established or senior investigators.
Amount: $110,000/ year for 5 years
Deadline: Elibility Phase; September 1, 2015
Leukemia and Lymphoma Society (LLS)
Scholar in Clinical Research Award
LLS's support of young investigators will continue to provide the foundation for the understanding and diagnosis of cancer, as well as the development of treatment and prevention options that will ultimately lead to cures for blood cancer patients. Applicants should have held a faculty-level, tenure-track position for less than or equal to 10 years at the time of review (January 1, 2016). There is a limit of 1 Fellow application per application cycle for each Sponsor, as well as 1 Special Fellow application per application cycle for each Sponsor. There is no limit to the number of applications submitted from a specific institution, nor is there a limit to the number of Scholar applications from any Sponsor. It is also acceptable for a Sponsor who currently has an active Fellow and/or Special Fellow Awardee in his/her lab to sponsor a Fellow and/or Special Fellow applicant during another award cycle. No other comparable (or better) career development award may be held prior to, or at the time of the grant start date (July 1, 2016). If a comparable (or better) career development award is obtained after receiving a Scholar in Clinical Research Award, the LLS Award must be relinquished. Applicants must be the PI on a peer-reviewed research grant from a national agency (e.g., NIH, NSF, ACS) or other independent source that supports the research costs of the proposed work. The Scholar in Clinical Research Award is intended to further develop the independent research careers of highly qualified investigators, not to support well-established or senior investigators. Applicants must have shown a capacity for independent, sustained, original clinical investigation in a field directly relevant to hematologic malignancies as documented in significant corresponding author publications in first tier, peer-reviewed journals.
Amount: $110,000/ year for 5 years
Deadline: LOI; September 1, 2015
The Arnold and Mabel Beckman Foundation
Beckman Young Investigators Program (BYI)
The BYI program funds promising young scientists early in their careers who have not yet received a major award from another organization. Proposals that already have substantial funding will not be considered for the BYI award. The BYI program is open to those within the first 3 years of a tenure-track position, or an equivalent independent research appointment, at an institution that conducts research in the chemical and life sciences. No applicant may apply for a BYI award more than 2 times.
Amount: $750,000 over 4 years
Deadline: LOI; September 2, 2015
Lymphoma Research Foundation (LRF)
Follicular Lymphoma Pathways Grant
LRF seeks proposals for high-quality research studies in follicular lymphoma (FL). Applications to this initiative must include the study of primary FL patient samples to assure relevance to the human disease. In addition, applicants are required to explicitly delineate how the proposed research will incorporate collaborative interactions between/among investigators in different disciplines (e.g. pathology and medical oncology, basic science research and clinical investigators) and/or different institutions. Applicants are encouraged to design proposals that will complement existing LRF-funded clinical projects; ongoing clinical trials/recently completed within the National Cancer Institute (NCI) Cancer Cooperative Groups, or investigator initiated clinical trials.
Amount: $150,000/ year for 3 years
Deadline: September 2, 2015
Lymphoma Research Foundation (LRF)
Clinical Investigator Career Development Award
This grant is designed to provide physician investigators with support to spend 35-50% of their time implementing clinical research studies in lymphoma. All projects must be focused on hypothesis-driven clinical research in lymphoma. Applicants must be advanced fellows or junior faculty members with at least 2 years (24 months) of fellowship or postdoctoral training and no more than 5 years of experience beyond completion of his/her fellowship or postdoctoral training (the five year limit may be non-sequential) at the start of the award period (March 1, 2016). The applicant may not simultaneously receive another competitive career development award (such as NIH K series awards, ASH Physician-Scientist Career Development Awards, American Cancer Society Mentored Research Scholar Grants, and equivalents) during the period of the LRF grant.
Amount: $225,000 over 3 years
Deadline: September 2, 2015
Concern Foundation
Conquer Cancer Now Award
Proposals must be hypothesis-driven and centered on cancer genetics, cancer cell biology, or cancer immunology. The Concern Foundation will not fund clinical trials, cancer epidemiology, or behavioral studies. Grants will only be awarded to independent investigators who are at the start of their scientific career (i.e., junior faculty) and are at the level of Assistant Professor (or equivalent with explanation). Priority will be given to proposals from independent investigators who have yet to obtain significant funding for their work. Applicants who are PI's on an existing R01 or equivalent are not eligible. Applicants who are notified prior to the full grant submission deadline of a clearly fundable score on an R01 or equivalent grant-in-review where he/she is PI are also not eligible.
Amount: $60,000/ year for 2 years
Deadline: LOI; September 9, 2015
Alpha-1 Foundation
Research Grants
The Alpha-1 Foundation will support research projects involving basic science, translational and clinical research, and ethical, legal, and social issues. The objective of this grant is to provide funds to encourage the development of new information that contributes to the understanding of the basic biology of alpha-1 antitrypsin expression, and the pathogenesis/management of AAT Deficiency. In addition, consideration will be given to those projects that provide insight into the development of information that may contribute to new therapies for AAT Deficiency. The PI should devote at least 10% effort to the Research Grant.
Amount: $100,000/ year for 2 years
Deadline: LOI; September 18, 2015
Alpha-1 Foundation
Pilot and Feasibility GrantsThe objective of this grant is to provide funds to encourage the development and testing of new hypotheses and/or new methods in research areas relevant to AAT Deficiency. Proposed work must be hypothesis-generating or hypothesis-testing, reflecting innovative approaches to important questions in AAT research or development of novel methods, and providing sufficient preliminary data to justify the Foundation's support. Results from Pilot and Feasibility Grants should lead to the submission of applications for funding from other agencies (i.e. NIH). Amount: $40,000 for 1 year Deadline: LOI; September 18, 2015 Alpha-1 Foundation Bridge GrantsThe objective of this grant is to provide support for excellent AAT-related research projects that have been submitted to and approved by the National Institutes of Health (NIH), but cannot be supported by the available NIH funds. Information derived from Alpha-1 Foundation supported research studies is intended to lead to solicitation of additional, subsequent funds from other agencies such as the NIH. Amount: $25,000 for 1 year Deadline: LOI; September 18, 2015 | American Society of Clinical Oncology (ASCO)
Conquer Cancer Foundation
Career Development Award (CDA)
The Conquer Cancer Foundation of ASCO CDA provides funding to clinical investigators who have received their initial faculty appointment to establish an independent clinical cancer research program. Applicants must be in the 1st to 3rd year of a full-time, primary faculty appointment in a clinical department at an academic medical institution at the time of grant submission. Applicants holding Instructor/Lecturer appointments are eligible to apply; however, the institutional letter of support must include information about the institution's commitment to support the applicant for the duration of the grant period. Applicants must be an ASCO member (Full Member or International Corresponding) or have submitted a membership application with the grant application. Applicants must be able to commit more than 50% of full-time effort in research (applies to total research, not just the proposed project) during the award period. Eligible physicians are allowed to hold only one grant from the Conquer Cancer Foundation at a time. Applicants must not have any current career development awards (ie. K23, K08, or any other type of career development award) and have not been a PI on any large project grants (ie. R01 or international equivalent, or private foundation grants). Past recipients of training fellowships (ie. Young Investigator Award or an F32 grant) are eligible. Applicants with institutional KL2/K12 grants are eligible to apply but will be asked to relinquish their institutional grant at the start of the CDA grant period (July 1, 2016).
Amount: $200,000 over 3 years
Deadline: September 24, 2015
American Cancer Society (ACS)
Jules L. Plangere Jr. Family Foundation Professor in Cancer Immunotherapy
This award is intended for an outstanding, mid-career investigator who has made seminal contributions to the field of cancer immunotherapy and who is an internationally recognized leader in the field. Applicants must be within 15 years of promotion to the rank of full Professor or the equivalent. For this award, department and division chairs are eligible to apply though administrative responsibilities will be evaluated during the review.
Amount: $80,000/ year for 5 years
Deadline: LOI; September 30, 2015
|
Non-Federal Funding-Fellowships
Leukemia & Lymphoma Society (LLS)
Special Fellow
LLS continues to support talented blood cancer researchers in the early phase of their careers. The Special Fellow Award is for 2 or 3 years, depending on eligibility. To be eligible for a Special Fellow Award, applicants must have had their oral thesis defense, or the end of their clinical education or training, on or more recent than July 1, 2012 (for a 3 year award) or July 1, 2011 (for a 2 year award). Applicants should have at least 2 years postdoctoral experience, but less than 4.5 years of experience at the time of review (January 1, 2016). Postdoctoral experience begins on the date of the oral thesis defense (or date of degree conferral, whichever comes first), or at the end of clinical education or training. Time spent in the thesis advisor's laboratory following the thesis defense is considered postdoctoral experience. Postdoctoral experience is not defined by the start date in the current laboratory. There is a limit of 1 Fellow application per application cycle for each Sponsor, as well as 1 Special Fellow application per application cycle for each Sponsor. There is no limit to the number of applications submitted from a specific institution, nor is there a limit to the number of Scholar applications from any Sponsor. It is also acceptable for a Sponsor who currently has an active Fellow and/or Special Fellow Awardee in his/her lab to sponsor a Fellow and/or Special Fellow applicant during another award cycle. No other comparable (or better) career development award may be held by an Applicant prior to the review panel meeting (January 1, 2016). However, applicants who are selected for an Award may receive other career development awards (e.g. NIH K Awards). The Sponsor must be the head of the laboratory where the applicant's research will be performed. An applicant's postdoctoral research must be in a laboratory different than where they performed their thesis research. In addition, their Sponsor must be different than their graduate supervisor. Applicants who leave their current laboratory between full application submission (October 1, 2015) and the Award start date (July 1, 2016) are not eligible for a Special Fellow Award. Acceptance of a Special Fellow Award requires that the recipient spend at least one year in the Sponsor's laboratory as a research fellow (July 1, 2016 - June 30, 2017) before moving to another position. LLS support may not extend postdoctoral research training (excluding clinical training) beyond 7 years. Applicants can apply for either 2 or 3 years of funding to comply with this requirement.
Amount: $65,000/ year for 2-3 years
Deadline: Eligibility phase; September 1, 2015
Leukemia & Lymphoma Society (LLS)
Fellow Award
To be eligible for a Fellow Award, applicants must have had their oral thesis defense, or the end of their clinical education or training, on or more recent than July 1, 2014. Applicants should have less than or equal to 2 years postdoctoral experience at the time of review (January 1, 2016). Postdoctoral experience begins on the date of the oral thesis defense (or date of degree conferral, whichever comes first), or at the end of clinical education or training. Time spent in the thesis advisor's laboratory following the thesis defense is considered postdoctoral experience. Postdoctoral experience is not defined by the start date in the current laboratory. There is a limit of one Fellow application per application cycle for each Sponsor, as well as one Special Fellow application per application cycle for each Sponsor. There is no limit to the number of applications submitted from a specific institution, nor is there a limit to the number of Scholar applications from any Sponsor. It is also acceptable for a Sponsor who currently has an active Fellow and/or Special Fellow Awardee in his/her lab to sponsor a Fellow and/or Special Fellow applicant during another award cycle. No other comparable (or better) career development award may be held prior to, or at the time of the grant start date (July 1, 2016). If a comparable (or better) career development award is obtained after receiving a Fellow Award, the LLS Award must be relinquished. The Sponsor must be the head of the laboratory where the applicant's research will be performed. An applicant's postdoctoral research must be in a laboratory different than where they performed their thesis research. In addition, their Sponsor must be different than their graduate supervisor. Applicants who transfer between full application submission (October 1, 2015) and the Award start date (July 1, 2016) are not eligible for a Fellow Award.
Amount: $55,000/ year for 3 years
Deadline: Eligibility phase; September 1, 2015
Lymphoma Research Foundation (LRF)
Postdoctoral Fellowships
LRF remains dedicated to finding a cure for lymphoma through an aggressively funded research program and by supporting the next generation of lymphoma researchers. LRF maintains a strong commitment to supporting young investigators and ensuring they can build a successful career in the field of lymphoma research. LRF Postdoctoral Fellowship grant is designed to support investigators at the level of advanced fellow, postdoctoral researcher, or junior faculty member in laboratory or clinic based research with results and conclusions that must be clearly relevant to the treatment, diagnosis or prevention of Hodgkin and/or non-Hodgkin lymphoma. Applicants must devote 80% of their time to research during the award period. Applicants must have completed 2 years (24 months) of their fellowship or postdoctoral work, or no more than 2 years as a junior faculty instructor or assistant professor at the start of the award period (March 1, 2016). LRF Fellow may not hold another competitively applied for fellowship award during the period of the LRF grant, except if the fellowship is awarded as part of an NIH Institutional Training Grant (T32/K12 or equivalent). Supply and material costs for the LRF Fellowship should be supported by another grant or from institutional funds. Applicants must provide evidence of adequate research support. A previous LRF Fellow shall not be granted support other than in exceptional circumstances, which is decided on a case-by-case basis.
Amount: $105,000 over 2 years
Deadline: September 2, 2015
Thrasher Research Fund
Early Career Awards
The Fund recognizes that young investigators may find it difficult to remain in pediatric research because of a lack of funding. Therefore, the purpose of this program is to encourage the development of medical research in child health by awarding small grants to new researchers, helping them gain a foothold in this important area. Those eligible to apply include: physicians who are in a residency/fellowship training program, or who completed that program no more than one year before the date of submission of the Concept Paper and postdoctoral researchers who received the doctoral level degree no more than 3 years prior to the date of submission of the Concept Paper. A new investigator who holds a National Institutes of Health (NIH) K award (including a K12 award) or a Clinical and Translational Science Award (CTSA) is not eligible to apply for the Early Career Award. A mentor may have only 1 Thrasher Research Fund Early Career Awardee at a time.
Amount: $25,000 for up to 2 years
Deadline: Concept Paper; September 11, 2015
The Hope Funds for Cancer Research
Postdoctoral Fellowship
The Hope Funds for Cancer Research is offering fellowships to postdoctoral scientists who propose to work on highly innovative research projects that challenge the traditional paradigms of understanding the causes, mechanisms, progression, disease markers, or risk factors for the most difficult-to-treat cancers, including pancreatic, lung, liver, sarcomas, esophageal, brain, gastric, bone and ovarian cancers, and rare leukemias, lymphomas and MDS. Applicants must conduct their proposed research under a sponsor who holds a formal appointment at the host institution. Applicants can apply prior to starting or during their postdoctoral appointments provided they have been formally accepted into the lab they are applying from, and current postdoctoral scientists must not have been in their Sponsor's lab for more than 2 years as of September 18, 2015. Applicants who have already accepted other postdoctoral research fellowship awards are not eligible.
Amount: $154,500 over 3 years
Deadline: September 18, 2015
Alpha-1 Foundation
Postdoctoral Research Fellowship Grant
The Alpha-1 Foundation is committed to finding a cure for Alpha-1 Antitrypsin Deficiency and to improving the lives of individuals affected by Alpha-1 worldwide. The objective of this grant is to provide support for postdoctoral research fellows who are starting their research careers and are working in the laboratories of established researchers or conducting research with the mentorship of established research. Applicants must indicate a commitment to AAT-related research by focusing 50% of their time to AAT Deficiency research or clinical practice.
Amount: $50,000/ year for 2 years
Deadline: LOI; September 18, 2015
American Society of Clinical Oncology (ASCO)
Conquer Cancer Foundation
Young Investigator Award (YIA)
The purpose of this award is to fund physicians during the transition from a fellowship program to a faculty appointment. The Conquer Cancer Foundation welcomes application submissions in all oncology sub-specialties. Applicants must be in the last 2 years of his/her final sub-specialty training at an academic medical institution at the time of grant submission. Applicants must be an ASCO member (Full Member, Member in Training, or International Corresponding) or have submitted a membership application with the grant application. Applicants must commit at least 60% of full-time effort in research (applies to total research, not just the proposed project) during the award period. Eligible physicians are allowed to hold only 1 grant from the Conquer Cancer Foundation at a time. Previous or current recipients of a Conquer Cancer Foundation of ASCO Young Investigator Translational Cancer Research Award or an AACR-Conquer Cancer Foundation of ASCO Young Investigator Translational Cancer Research Award are not eligible. Applicants may concurrently apply for the Conquer Cancer Foundation Young Investigator Award and the AACR-Conquer Cancer Foundation of ASCO Young Investigator Translational Cancer Research Award. However,applicants are expected to accept the first grant they are awarded.
Amount: $50,000 for 1 year
Deadline: September 24, 2015
|
|
Search for Funding Using SPIN
DFCI subscribes to InfoEd International SPIN ™
SPIN
InfoEd's SPIN (Sponsored Programs Information Network) currently contains information from more than 10,000 different sponsoring agencies, which together fund over 40,000 separate funding opportunities. Options include features such as: Quick Search, Advanced Searching Capabilities, and the Federal Register. Please see the 'Training Videos' on the SPIN site for more information on SPIN and its features.
Please ensure that you have logged into InfoEd in the web browser you are using, otherwise you will not be able to access SPIN. |
|
|
|
